UBS Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.7K | Buy |
|
|||||
|
2025
Q1 | $939 | Sell |
|
|||||
|
2024
Q4 | $2.08K | Buy |
|
|||||
|
2024
Q3 | $373 | Hold |
|
|||||
|
2024
Q2 | $360 | Sell |
|
|||||
|
2024
Q1 | $536 | Hold |
|
|||||
|
2023
Q4 | $530 | Sell |
|
|||||
|
2023
Q3 | $7.47K | Buy |
|
|||||
|
2023
Q2 | $1.37K | Buy |
|
|||||
|
2023
Q1 | $507 | Sell |
|
|||||
|
2022
Q4 | $29.4K | Buy |
|
|||||
|
2022
Q3 | $44K | Buy |
|
|||||
|
2022
Q2 | $56K | Sell |
|
|||||
|
2022
Q1 | $158K | Buy |
|
|||||
|
2021
Q4 | $197K | Sell |
|
|||||
|
2021
Q3 | $1.56M | Buy |
|
|||||
|
2021
Q2 | $537K | Sell |
|
|||||
|
2021
Q1 | $1.29M | Buy |
|
|||||
|
2020
Q4 | $293K | Sell |
|
|||||
|
2020
Q3 | $1.02M | Sell |
|
|||||
|
2020
Q2 | $1.06M | Sell |
|
|||||
|
2020
Q1 | $1.19M | Sell |
|
|||||
|
2019
Q4 | $1.51M | Buy |
|
|||||
|
2019
Q3 | $418K | Buy |
|
|||||
|
2019
Q2 | $290K | Buy |
|